Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSodium valproate: an old drug with new roles
Trends in Pharmacological Sciences, 09/18/09
Nalivaeva NN et al. – There is now accumulating evidence that HDAC inhibitors may have potential in the treatment of CNS disorders and, in this context, valproate has much potential as a brain–penetrant, clinically available and well tested drug.
Related Articles
Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid
Clinical Infectious Diseases, 11/16/09
Relevance Score: 66%
Valproic acid-induced encephalopathy in very long course treated patients
Brain Injury, 10/22/09
Relevance Score: 65%
Risk factors for valproic acid resistance in childhood absence epilepsy
Seizure - European Journal of Epilepsy, 10/21/09
Relevance Score: 64%
Multiple organ dysfunction syndrome: infection or hypersensitivity reaction
European Journal of Emergency Medicine, 10/12/09
Relevance Score: 64%
Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells
British Journal of Haematology, 10/08/09
Relevance Score: 64%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phenylephrine but not Ephedrine Reduces Frontal Lobe Oxygenation Following Anesthesia-Induced Hypotension
Neurocritical Care , 12/16/09
An Herbal Nasal Drop Enhanced Frontal and Anterior Cingulate Cortex Activity
Evidence-based Complementary and Alternative Medicine , 12/16/09
Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor